A Daily Network publication
Explore the network
Private Wealth Daily
Independent Intelligence on the Private Wealth Industry
Friday, October 2, 2026The Morning Brief →Sign in

Who holds CRSPCRISPR THERAPEUTICS AG

13 funds on our shelf carry CRISPR THERAPEUTICS AG — heaviest hand: GNOM at 2.68% of its book.

FundWeightFund assetsShares held
GNOMGlobal X Genomics & Biotechnology ETFINDEX2.68%$85M49,773
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.39%$282M74,368
XBIState Street SPDR S&P Biotech ETFINDEX1.02%$11B2,006,430
IBBiShares Biotechnology ETFINDEX0.35%$10.7B705,711
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.35%$102M6,830
VTWVVanguard Russell 2000 Value ETFINDEX0.30%$813M75,907
IWNiShares Russell 2000 Value ETFINDEX0.28%$14.2B759,792
RSSLGlobal X Russell 2000 ETFINDEX0.17%$1.5B43,061
IWMiShares Russell 2000 ETFINDEX0.17%$78B2,352,325
VTWOVanguard Russell 2000 ETFINDEX0.17%$9.9B535,930
ISCViShares Morningstar Small-Cap Value ETFINDEX0.16%$672M20,690
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFINDEX0.11%$352M6,860
XTiShares Exponential Technologies ETFINDEX0.03%$4.1B18,651

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The private wealth industry in four minutes, every weekday at 6:30 a.m. ET. Free.